Programma didattico

Day 1 (10 September 2026)

 

13.30-14.00    Welcome light lunch

14.00-14.20    Meeting starts – P. Lampertico

 

Session 1 –     Viral Hepatitis – Moderators: P. Lampertico and R. D’Ambrosio

 

14.20-14.40    The HCV cascade of care: lessons learned and remaining gaps – P. Toniutto (UD)

14.40-15.00    Discussion

15.00-15.20    Therapeutics insights in HBV and HDV: current standards and future perspectives – E. Degasperi (MI)

15.20-15.40    Discussion

15.40-16.00    Case Presentation 1 – HBV prophylaxis in the era of immunotherapies – M.P. Anolli (MI)

 

16.00-16.20    Discussion

 

16.20-16.40    Coffee Break

 

 

Session 2 –     Multidisciplinary approach to HCC – Moderators: A. Sangiovanni and P. Toniutto

 

16.40-17.50    Case presentation 2 -  HCC 2026 – E. Alimenti (MI)

Expert Panel

Surgeon – B Antonelli (MI)

Radiologist – S. Crespi (MI)

Hepatologist – M. Iavarone (MI)

 

17.50-18.10    Transplant oncology: focus on colorectal cancer and cholangiocarcinoma – U. Cillo (PD)

18.10-18.30    Discussion

 

18.30-18.40    Meeting closes – P. Lampertico

 

20.00               Dinner with the Experts

 

 

 

 

Day 2 (11 September 2026)

 

Session 3 –     Liver Transplantation – Moderators: C. Quintini and P. Toniutto

 

8.30-8.50        Shifting paradigms in the Italian liver transplant scenario: a 2026 update – S. Trapani (RM)

8.30-9.10        Discussion

9.10-9.30        Optimizing patient selection for liver transplant: current standards – P. Toniutto (UD)

9.30-9.50        Discussion

9.50-10.10      Case Presentation 3 – Liver transplant in the era of expanded oncological criteria – C. Dibenedetto (MI)

10.10-10.30    Discussion

10.30-10.50    New frontiers in liver transplant: splitting, bio-engineering and xenografts – C. Quintini (MI)

10.50-11.10    Discussion

 

 

11.10-11.20    Coffee Break

 

 

Session 4 –     New therapeutics – Moderators: R. D’Ambrosio and S. Petta

 

11.20-11.40    Managing MASLD/MASH: from patient selection to therapeutic intervention – S. Petta (PA)

11.40-12.00    Discussion

12.00-12.20    Targeting metabolic pathways in primary cholangiopathies: the emergence of next-generation therapies – L. Cristofori (MB)

12.20-12.40    Discussion

12.40-13.00    Case Presentation 4 – Post-transplant recurrence of PSC – M. Sagasta (MI)

 

13.10-13.30    Discussion

 

 

13.30-14.30    Light Lunch

 

 

Session 5 –     Portal Hypertension – Moderators: M. Iavarone and P. Toniutto

 

14.30-14.50    From Baveno VII to Baveno VIII: navigating the evolution of portal hypertension – G. Tosetti (MI)

14.50-15.10    Discussion

15.10-15.30    Case Presentation 5 – Redefining PSVD criteria – M. Lucà (MI)

15.30-15.50    Discussion

 

 

Session 6 – Round Table – Moderators: P. Lampertico and C. Quintini

 

 

15.50-16.30    Optimizing the hub and spoke model in liver diseases: shared experience and future networks

Discussants: Faculty and attendees

 

16.30 -16.40   Meeting Closes and ECM